PFIZER-BIONTECH COVID-19 VACCINE

Nazione: Indonesia

Lingua: indonesiano

Fonte: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Principio attivo:

BNT162B2 (MRNA OF SARS-COV 2 VIRUS SPIKE PROTEIN)

Commercializzato da:

BIO FARMA - Indonesia

INN (Nome Internazionale):

BNT162B2 (MRNA OF SARS-COV 2 VIRUS SPIKE PROTEIN)

Dosaggio:

30 MCG

Forma farmaceutica:

INJEKSI

Confezione:

DUS, 195 VIAL @ 6 DOSIS + DUS, 25 DILUENT VIAL @ 10 ML NACL 0.9%

Prodotto da:

HOSPIRA, INC. - United States of America

Data dell'autorizzazione:

2021-11-29

Scheda tecnica

Bahasa Inggris
PHARMALENE B
Adapalene
Benzoyl Peroxide
Gel
Composition :
Each gram of gel contains :
Adapalene
.............................................................................................................
1 mg
Benzoyl Peroxide
.................................................................................................
25 mg
Mechanism of action:
Adapalene acts on retinoid receptors. Mechanistically, Adapalene binds
to specific Retinoic acid
nuclear receptors but it does not bind to the cytosolic receptor
protein. Although the exact mode of
action of Adapalene is unknown, it is suggested that topical Adapalene
normalizes the differentiation
of follicular epithelial cells resulting in decreased microcomedone
formation.
Benzoyl Peroxide is an antibacterial agent which is believed to act by
oxidizing proteins, including
bacterial proteins, and reducing the population of Propionibacterium
acnes which are usually
abnormally present in the acne-affected pilosebaceous unit. Therefore,
Adapalene and Benzoyl
Peroxide act through different, but complementary, mechanisms that
affect different aspects of
acne therapy.
Indication :
Pharmalene B is indicated for the topical treatment of acne vulgaris
in patients 12 years of age and
older.
Dosage and administrations :
Apply a thin film of Pharmalene B to affected areas of the face and/or
trunk once daily after washing
with a mild or soapless cleanser. Use a pea-sized amount for each area
of the face (e.g., forehead,
chin, each cheek).
Avoid the eyes, lips and mucous membranes. Pharmalene B is not for
oral, opthalmic, or intravaginal
use.
•The product can be used within 60 days after opened.
DISETUJUI OLEH BPOM: 23/01/2020
ID: EREG10023811800025
Contraindication :
Patients with history of hypersensitivity to Adapalene, Benzoyl
Peroxide or to any other component
of this preparation.
Adverse Reactions :
If skin irritation appears after application of Pharmalene B, the
intensity is generally mild or
moderate, with local tolerability signs and symptoms [erythema